Venus Remedies gets huge global acclaim with UNICEF GMP approval
· Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
· This achievement is an endorsement of Venus Remedies' commitment to delivering top-quality pharmaceutical products worldwide
Mumbai, March 11, 2024: Venus Remedies Limited, a leading global pharmaceutical company, has recently secured Good Manufacturing Practices (GMP) approval from the United Nations International Children's Emergency Fund (UNICEF). This milestone underscores Venus Remedies' commitment to delivering top-quality pharmaceutical solutions worldwide.
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, India, has been recommended for supplying cephalosporin dry powder, a class of β-lactam antibiotic for treating bacterial infections, to UNICEF. The company's adherence to the highest standards of manufacturing excellence, as evident by its compliance with WHO Technical Report Series 986, reinforces its position as a trusted partner in global healthcare supply chains.
With this approval, Venus Remedies continues to strengthen its international presence, building upon its extensive portfolio of certifications from regulatory bodies worldwide. "This recognition from UNICEF further validates our relentless pursuit of excellence in pharmaceutical manufacturing. The approval will further help us make substantial contributions to global healthcare initiatives of UNICEF and positively influence communities worldwide,” said Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre.
The approval from UNICEF will enable Venus Remedies to partake in opportunities for the supply of essential medications, enabling the company to address critical healthcare needs in regions facing health challenges owing to lack of access to medicines. Akshansh Chaudhary, Executive Director, Venus Remedies, emphasised the significance of this approval, saying, "This endorsement from UNICEF is aligned with our mission to enhance access to quality healthcare globally. We look forward to leveraging this opportunity to extend our reach and serve those in need."
UNICEF, an esteemed agency of the United Nations, is recognised globally for its efforts in providing humanitarian aid and developmental support to children in need. Its rigorous GMP approval process sets a benchmark for quality and safety in pharmaceutical production, and Venus Remedies' accreditation demonstrates its uncompromising adherence to these stringent standards.
UNICEF provides humanitarian and developmental assistance to children worldwide. With a presence in over 190 countries, it works tirelessly to protect the rights and well-being of children regardless of their background or circumstances.
About Venus Remedies
Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 70+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. Its manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS. The company has also been approved by European- GMP, WHO-GMP and Latin American GMP (INVIMA), among others. Ranked 107th in Asia and among the world’s 500 largest pharmaceutical manufacturing companies, Venus Remedies has been granted more than 130 patents worldwide and having more than 125 registered trademarks and 25 copyrights for its innovative research products.
0 Comments